Purigen Biosystems' innovative products offer a truly transformative solution for DNA and RNA purification. Our proprietary approach uses isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface. Because of this, our technology is agnostic to nucleic acid size or sequence and delivers unbiased results ― even from the more challenging sample types like FFPE tissue or low cell counts. Our Ionic Purification System and Kits combine to provide researchers with a fast, efficient and effective alternative for automated nucleic acid purification.
Location: United States, California, Pleasanton
Employees: 11-50
Phone: +1 877-787-4436
Total raised: $44.6M
Founded date: 2012
Investors 2
| Date | Name | Website |
| - | 5AM Ventur... | 5amventure... |
| - | Cota Capit... | cotacapita... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.06.2019 | Series B | $26.4M | - |
| 18.05.2016 | Series A | $18.2M | 5AM Ventur... |
Mentions in press and media 9
| Date | Title | Description |
| 13.06.2019 | Why Bird Wants to Buy Smaller Electric Scooter Rival Scoot: Term Sheet | SCOOTING INTO SAN FRANCISCO The crowded scooter market is starting to consolidate. Paid Content Securing the enterprise without boundaries From ExtraHop So why Scoot? The second I saw the news, I thought “Duh, it’s about San Francisco.” Rem... |
| 12.06.2019 | Purigen Biosystems Raises $26.4M Series B | PLEASANTON, CA, Purigen Biosystems announced the completion of a $26.4 million Series B financing. >> Click here for more funding data on Purigen Biosystems >> To export Purigen Biosystems funding data to PDF and Excel, clic... |
| 12.06.2019 | Purigen Biosystems Closes $26.4M Series B Financing | Purigen Biosystems, Inc., a Pleasanton, Calif.-based provider of next-generation technologies for extracting, enriching, and quantifying nucleic acids from biological samples, closed a $26.4m Series B financing. The round was led by Agilent... |
| 12.06.2019 | Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform | - |
| 30.05.2016 | 5AM Ventures has raised $285M for fifth fund (Updated) | Update On Monday, it confirmed the amount in a press release on its website. In a phone interview with 5AM Founder and Managing Partner Andrew Schwab he confirmed that 5AM Ventures V would be similar to 5 AM Ventures IV. Its investment targ... |
| 18.05.2016 | Purigen Biosystems Nets $18.2M in Series A | PLEASANTON, CA, Leader in the development of technology for genomics sample preparation, has announced the completion of an $18.2M Series A financing. >> Click here for more funding data on Purigen Biosystems >> To export Pu... |
| 17.05.2016 | Purigen Biosystems Completes $18.2M Series A Funding | Purigen Biosystems, a Pleasanton, CA-based developer of technology for genomics sample preparation, completed an $18.2M Series A funding. Backers included 5AM Ventures, Roche Venture Fund and existing investors the Stanford-Startx Fund and ... |
| 17.05.2016 | PURIGEN BIOSYSTEMS RECEIVES $18.2M IN SERIES A FINANCING LED BY 5AM VENTURES AND ROCHE VENTURE FUND | - |
| - | 5AM Ventures has raised $285M for fifth fund (Updated) | This post has been updated from an earlier version with comments from 5AM Ventures Founder and Managing Partner Andrew Schwab. Life science venture firm 5AM Ventures has raised $285 million for fund number 5, according to data from a Form D... |